RecruitingNot ApplicableNCT04320199

Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease

Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease: a Randomized Controlled Trial

Sponsor

Pusan National University Yangsan Hospital

Enrollment

30 participants

Start Date

Jan 1, 2020

Study Type

INTERVENTIONAL

Conditions

Alcoholic Liver Disease

Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Fermented Protaetia brevitarsis seulensis powder on Alcohol-induced Liver Disease in adults for 8 weeks.

Eligibility

Min Age: 19 Years

Inclusion Criteria1

Gamma-glutamyl transferase ranging from upper limit of reference to four times of upper limit

Exclusion Criteria8

Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times of upper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)
Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)
History of viral hepatitis or cancer
Uncontrolled hypertension
History of serious cardiac disease such as angina or myocardial infarction
History of gastrectomy
History of medication for psychiatric disease
Administration of oriental medicine including herbs within the past 4 weeks